Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Roadzen (RDZNW) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for Roadzen (RDZNW) over the last 3 years, with Q4 2025 value amounting to $5.1 million.

  • Roadzen's Cash & Equivalents fell 1151.75% to $5.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.1 million, marking a year-over-year decrease of 1151.75%. This contributed to the annual value of $4.8 million for FY2025, which is 5676.26% down from last year.
  • Roadzen's Cash & Equivalents amounted to $5.1 million in Q4 2025, which was down 1151.75% from $5.0 million recorded in Q3 2025.
  • Roadzen's 5-year Cash & Equivalents high stood at $11.2 million for Q1 2024, and its period low was $589340.0 during Q1 2023.
  • Its 3-year average for Cash & Equivalents is $6.1 million, with a median of $5.8 million in 2024.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 179807.16% in 2024, then plummeted by 5982.14% in 2025.
  • Quarter analysis of 3 years shows Roadzen's Cash & Equivalents stood at $9.4 million in 2023, then tumbled by 38.2% to $5.8 million in 2024, then decreased by 11.52% to $5.1 million in 2025.
  • Its Cash & Equivalents was $5.1 million in Q4 2025, compared to $5.0 million in Q3 2025 and $3.1 million in Q2 2025.